nodes	percent_of_prediction	percent_of_DWPC	metapath
Darunavir—CYP3A4—Tamoxifen—pancreatic cancer	0.0834	0.24	CbGbCtD
Darunavir—CYP3A4—Erlotinib—pancreatic cancer	0.0709	0.204	CbGbCtD
Darunavir—CYP3A4—Irinotecan—pancreatic cancer	0.0641	0.185	CbGbCtD
Darunavir—CYP3A4—Docetaxel—pancreatic cancer	0.0469	0.135	CbGbCtD
Darunavir—CYP3A4—Sunitinib—pancreatic cancer	0.0467	0.135	CbGbCtD
Darunavir—CYP3A4—Doxorubicin—pancreatic cancer	0.035	0.101	CbGbCtD
Darunavir—Angina pectoris—Doxorubicin—pancreatic cancer	0.000322	0.000493	CcSEcCtD
Darunavir—Hypersensitivity—Irinotecan—pancreatic cancer	0.000321	0.000492	CcSEcCtD
Darunavir—Convulsion—Docetaxel—pancreatic cancer	0.00032	0.00049	CcSEcCtD
Darunavir—Hypertension—Docetaxel—pancreatic cancer	0.000319	0.000488	CcSEcCtD
Darunavir—Infestation NOS—Epirubicin—pancreatic cancer	0.000318	0.000488	CcSEcCtD
Darunavir—Infestation—Epirubicin—pancreatic cancer	0.000318	0.000488	CcSEcCtD
Darunavir—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000316	0.000484	CcSEcCtD
Darunavir—Myalgia—Docetaxel—pancreatic cancer	0.000314	0.000481	CcSEcCtD
Darunavir—Chest pain—Docetaxel—pancreatic cancer	0.000314	0.000481	CcSEcCtD
Darunavir—Arthralgia—Docetaxel—pancreatic cancer	0.000314	0.000481	CcSEcCtD
Darunavir—Nausea—Sunitinib—pancreatic cancer	0.000314	0.000481	CcSEcCtD
Darunavir—Pancytopenia—Doxorubicin—pancreatic cancer	0.000314	0.000481	CcSEcCtD
Darunavir—Renal failure—Epirubicin—pancreatic cancer	0.000313	0.000479	CcSEcCtD
Darunavir—Asthenia—Irinotecan—pancreatic cancer	0.000313	0.000479	CcSEcCtD
Darunavir—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000312	0.000478	CcSEcCtD
Darunavir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000312	0.000478	CcSEcCtD
Darunavir—Stomatitis—Epirubicin—pancreatic cancer	0.00031	0.000475	CcSEcCtD
Darunavir—Jaundice—Epirubicin—pancreatic cancer	0.00031	0.000475	CcSEcCtD
Darunavir—Neutropenia—Doxorubicin—pancreatic cancer	0.000309	0.000473	CcSEcCtD
Darunavir—Dysuria—Doxorubicin—pancreatic cancer	0.000309	0.000473	CcSEcCtD
Darunavir—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000307	0.000471	CcSEcCtD
Darunavir—Dry mouth—Docetaxel—pancreatic cancer	0.000307	0.000471	CcSEcCtD
Darunavir—Pollakiuria—Doxorubicin—pancreatic cancer	0.000305	0.000468	CcSEcCtD
Darunavir—Asthenia—Gemcitabine—pancreatic cancer	0.000304	0.000466	CcSEcCtD
Darunavir—Haematuria—Epirubicin—pancreatic cancer	0.000304	0.000465	CcSEcCtD
Darunavir—Confusional state—Docetaxel—pancreatic cancer	0.000304	0.000465	CcSEcCtD
Darunavir—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000301	0.000461	CcSEcCtD
Darunavir—Weight increased—Doxorubicin—pancreatic cancer	0.000301	0.000461	CcSEcCtD
Darunavir—Epistaxis—Epirubicin—pancreatic cancer	0.0003	0.00046	CcSEcCtD
Darunavir—Pruritus—Gemcitabine—pancreatic cancer	0.0003	0.00046	CcSEcCtD
Darunavir—Weight decreased—Doxorubicin—pancreatic cancer	0.000299	0.000458	CcSEcCtD
Darunavir—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000298	0.000457	CcSEcCtD
Darunavir—Diarrhoea—Irinotecan—pancreatic cancer	0.000298	0.000456	CcSEcCtD
Darunavir—Shock—Docetaxel—pancreatic cancer	0.000296	0.000454	CcSEcCtD
Darunavir—Nervous system disorder—Docetaxel—pancreatic cancer	0.000295	0.000452	CcSEcCtD
Darunavir—Pruritus—Fluorouracil—pancreatic cancer	0.000295	0.000452	CcSEcCtD
Darunavir—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000295	0.000452	CcSEcCtD
Darunavir—Infestation—Doxorubicin—pancreatic cancer	0.000295	0.000451	CcSEcCtD
Darunavir—Infestation NOS—Doxorubicin—pancreatic cancer	0.000295	0.000451	CcSEcCtD
Darunavir—Tachycardia—Docetaxel—pancreatic cancer	0.000294	0.00045	CcSEcCtD
Darunavir—Skin disorder—Docetaxel—pancreatic cancer	0.000292	0.000448	CcSEcCtD
Darunavir—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000292	0.000447	CcSEcCtD
Darunavir—Bradycardia—Epirubicin—pancreatic cancer	0.000291	0.000446	CcSEcCtD
Darunavir—Diarrhoea—Gemcitabine—pancreatic cancer	0.00029	0.000445	CcSEcCtD
Darunavir—Renal failure—Doxorubicin—pancreatic cancer	0.00029	0.000444	CcSEcCtD
Darunavir—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000289	0.000442	CcSEcCtD
Darunavir—Dizziness—Irinotecan—pancreatic cancer	0.000288	0.000441	CcSEcCtD
Darunavir—Haemoglobin—Epirubicin—pancreatic cancer	0.000287	0.00044	CcSEcCtD
Darunavir—Stomatitis—Doxorubicin—pancreatic cancer	0.000287	0.00044	CcSEcCtD
Darunavir—Jaundice—Doxorubicin—pancreatic cancer	0.000287	0.00044	CcSEcCtD
Darunavir—Anorexia—Docetaxel—pancreatic cancer	0.000287	0.00044	CcSEcCtD
Darunavir—Haemorrhage—Epirubicin—pancreatic cancer	0.000286	0.000438	CcSEcCtD
Darunavir—Hepatitis—Epirubicin—pancreatic cancer	0.000286	0.000438	CcSEcCtD
Darunavir—Diarrhoea—Fluorouracil—pancreatic cancer	0.000285	0.000437	CcSEcCtD
Darunavir—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000284	0.000436	CcSEcCtD
Darunavir—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000282	0.000432	CcSEcCtD
Darunavir—Oedema peripheral—Epirubicin—pancreatic cancer	0.000282	0.000431	CcSEcCtD
Darunavir—Haematuria—Doxorubicin—pancreatic cancer	0.000281	0.00043	CcSEcCtD
Darunavir—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000281	0.00043	CcSEcCtD
Darunavir—Urethral disorder—Epirubicin—pancreatic cancer	0.00028	0.000429	CcSEcCtD
Darunavir—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000279	0.000427	CcSEcCtD
Darunavir—Epistaxis—Doxorubicin—pancreatic cancer	0.000278	0.000426	CcSEcCtD
Darunavir—Vomiting—Irinotecan—pancreatic cancer	0.000277	0.000424	CcSEcCtD
Darunavir—Dizziness—Fluorouracil—pancreatic cancer	0.000276	0.000423	CcSEcCtD
Darunavir—Visual impairment—Epirubicin—pancreatic cancer	0.000276	0.000422	CcSEcCtD
Darunavir—Rash—Irinotecan—pancreatic cancer	0.000275	0.000421	CcSEcCtD
Darunavir—Dermatitis—Irinotecan—pancreatic cancer	0.000274	0.00042	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000274	0.00042	CcSEcCtD
Darunavir—Headache—Irinotecan—pancreatic cancer	0.000273	0.000418	CcSEcCtD
Darunavir—Insomnia—Docetaxel—pancreatic cancer	0.000272	0.000417	CcSEcCtD
Darunavir—Paraesthesia—Docetaxel—pancreatic cancer	0.00027	0.000414	CcSEcCtD
Darunavir—Erythema multiforme—Epirubicin—pancreatic cancer	0.00027	0.000414	CcSEcCtD
Darunavir—Vomiting—Gemcitabine—pancreatic cancer	0.00027	0.000413	CcSEcCtD
Darunavir—Bradycardia—Doxorubicin—pancreatic cancer	0.000269	0.000412	CcSEcCtD
Darunavir—Dyspnoea—Docetaxel—pancreatic cancer	0.000268	0.000411	CcSEcCtD
Darunavir—Somnolence—Docetaxel—pancreatic cancer	0.000268	0.00041	CcSEcCtD
Darunavir—Rash—Gemcitabine—pancreatic cancer	0.000268	0.00041	CcSEcCtD
Darunavir—Dermatitis—Gemcitabine—pancreatic cancer	0.000267	0.000409	CcSEcCtD
Darunavir—Eye disorder—Epirubicin—pancreatic cancer	0.000267	0.000409	CcSEcCtD
Darunavir—Haemoglobin—Doxorubicin—pancreatic cancer	0.000266	0.000407	CcSEcCtD
Darunavir—Headache—Gemcitabine—pancreatic cancer	0.000266	0.000407	CcSEcCtD
Darunavir—Flushing—Epirubicin—pancreatic cancer	0.000265	0.000406	CcSEcCtD
Darunavir—Cardiac disorder—Epirubicin—pancreatic cancer	0.000265	0.000406	CcSEcCtD
Darunavir—Vomiting—Fluorouracil—pancreatic cancer	0.000265	0.000406	CcSEcCtD
Darunavir—Dyspepsia—Docetaxel—pancreatic cancer	0.000265	0.000406	CcSEcCtD
Darunavir—Haemorrhage—Doxorubicin—pancreatic cancer	0.000265	0.000405	CcSEcCtD
Darunavir—Hepatitis—Doxorubicin—pancreatic cancer	0.000265	0.000405	CcSEcCtD
Darunavir—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000263	0.000403	CcSEcCtD
Darunavir—Rash—Fluorouracil—pancreatic cancer	0.000263	0.000403	CcSEcCtD
Darunavir—Dermatitis—Fluorouracil—pancreatic cancer	0.000263	0.000403	CcSEcCtD
Darunavir—Decreased appetite—Docetaxel—pancreatic cancer	0.000262	0.000401	CcSEcCtD
Darunavir—Headache—Fluorouracil—pancreatic cancer	0.000261	0.0004	CcSEcCtD
Darunavir—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000261	0.0004	CcSEcCtD
Darunavir—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000261	0.000399	CcSEcCtD
Darunavir—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.00026	0.000398	CcSEcCtD
Darunavir—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.00026	0.000398	CcSEcCtD
Darunavir—Fatigue—Docetaxel—pancreatic cancer	0.00026	0.000398	CcSEcCtD
Darunavir—Angiopathy—Epirubicin—pancreatic cancer	0.000259	0.000397	CcSEcCtD
Darunavir—Urethral disorder—Doxorubicin—pancreatic cancer	0.000259	0.000397	CcSEcCtD
Darunavir—Nausea—Irinotecan—pancreatic cancer	0.000259	0.000396	CcSEcCtD
Darunavir—Immune system disorder—Epirubicin—pancreatic cancer	0.000258	0.000395	CcSEcCtD
Darunavir—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000258	0.000395	CcSEcCtD
Darunavir—Pain—Docetaxel—pancreatic cancer	0.000258	0.000394	CcSEcCtD
Darunavir—Constipation—Docetaxel—pancreatic cancer	0.000258	0.000394	CcSEcCtD
Darunavir—Chills—Epirubicin—pancreatic cancer	0.000257	0.000393	CcSEcCtD
Darunavir—Visual impairment—Doxorubicin—pancreatic cancer	0.000255	0.00039	CcSEcCtD
Darunavir—Alopecia—Epirubicin—pancreatic cancer	0.000253	0.000387	CcSEcCtD
Darunavir—Nausea—Gemcitabine—pancreatic cancer	0.000252	0.000386	CcSEcCtD
Darunavir—Mental disorder—Epirubicin—pancreatic cancer	0.00025	0.000384	CcSEcCtD
Darunavir—Erythema multiforme—Doxorubicin—pancreatic cancer	0.00025	0.000383	CcSEcCtD
Darunavir—Malnutrition—Epirubicin—pancreatic cancer	0.000249	0.000381	CcSEcCtD
Darunavir—Erythema—Epirubicin—pancreatic cancer	0.000249	0.000381	CcSEcCtD
Darunavir—Feeling abnormal—Docetaxel—pancreatic cancer	0.000248	0.00038	CcSEcCtD
Darunavir—Nausea—Fluorouracil—pancreatic cancer	0.000248	0.00038	CcSEcCtD
Darunavir—Eye disorder—Doxorubicin—pancreatic cancer	0.000247	0.000379	CcSEcCtD
Darunavir—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000246	0.000377	CcSEcCtD
Darunavir—Flushing—Doxorubicin—pancreatic cancer	0.000246	0.000376	CcSEcCtD
Darunavir—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000246	0.000376	CcSEcCtD
Darunavir—Flatulence—Epirubicin—pancreatic cancer	0.000245	0.000376	CcSEcCtD
Darunavir—Dysgeusia—Epirubicin—pancreatic cancer	0.000244	0.000373	CcSEcCtD
Darunavir—Angiopathy—Doxorubicin—pancreatic cancer	0.00024	0.000368	CcSEcCtD
Darunavir—Muscle spasms—Epirubicin—pancreatic cancer	0.000239	0.000366	CcSEcCtD
Darunavir—Immune system disorder—Doxorubicin—pancreatic cancer	0.000239	0.000366	CcSEcCtD
Darunavir—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000238	0.000365	CcSEcCtD
Darunavir—Abdominal pain—Docetaxel—pancreatic cancer	0.000238	0.000365	CcSEcCtD
Darunavir—Body temperature increased—Docetaxel—pancreatic cancer	0.000238	0.000365	CcSEcCtD
Darunavir—Chills—Doxorubicin—pancreatic cancer	0.000237	0.000364	CcSEcCtD
Darunavir—Alopecia—Doxorubicin—pancreatic cancer	0.000234	0.000358	CcSEcCtD
Darunavir—Mental disorder—Doxorubicin—pancreatic cancer	0.000232	0.000355	CcSEcCtD
Darunavir—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000231	0.000354	CcSEcCtD
Darunavir—Malnutrition—Doxorubicin—pancreatic cancer	0.00023	0.000353	CcSEcCtD
Darunavir—Erythema—Doxorubicin—pancreatic cancer	0.00023	0.000353	CcSEcCtD
Darunavir—Anaemia—Epirubicin—pancreatic cancer	0.00023	0.000352	CcSEcCtD
Darunavir—Agitation—Epirubicin—pancreatic cancer	0.000229	0.00035	CcSEcCtD
Darunavir—Flatulence—Doxorubicin—pancreatic cancer	0.000227	0.000348	CcSEcCtD
Darunavir—Dysgeusia—Doxorubicin—pancreatic cancer	0.000226	0.000345	CcSEcCtD
Darunavir—Malaise—Epirubicin—pancreatic cancer	0.000224	0.000344	CcSEcCtD
Darunavir—Vertigo—Epirubicin—pancreatic cancer	0.000224	0.000342	CcSEcCtD
Darunavir—Syncope—Epirubicin—pancreatic cancer	0.000223	0.000342	CcSEcCtD
Darunavir—Leukopenia—Epirubicin—pancreatic cancer	0.000223	0.000341	CcSEcCtD
Darunavir—Hypersensitivity—Docetaxel—pancreatic cancer	0.000222	0.00034	CcSEcCtD
Darunavir—Muscle spasms—Doxorubicin—pancreatic cancer	0.000221	0.000339	CcSEcCtD
Darunavir—Palpitations—Epirubicin—pancreatic cancer	0.00022	0.000337	CcSEcCtD
Darunavir—Loss of consciousness—Epirubicin—pancreatic cancer	0.000219	0.000335	CcSEcCtD
Darunavir—Cough—Epirubicin—pancreatic cancer	0.000217	0.000333	CcSEcCtD
Darunavir—Asthenia—Docetaxel—pancreatic cancer	0.000216	0.000331	CcSEcCtD
Darunavir—Convulsion—Epirubicin—pancreatic cancer	0.000216	0.00033	CcSEcCtD
Darunavir—Hypertension—Epirubicin—pancreatic cancer	0.000215	0.000329	CcSEcCtD
Darunavir—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000214	0.000327	CcSEcCtD
Darunavir—Pruritus—Docetaxel—pancreatic cancer	0.000213	0.000326	CcSEcCtD
Darunavir—Anaemia—Doxorubicin—pancreatic cancer	0.000213	0.000326	CcSEcCtD
Darunavir—Arthralgia—Epirubicin—pancreatic cancer	0.000212	0.000325	CcSEcCtD
Darunavir—Myalgia—Epirubicin—pancreatic cancer	0.000212	0.000325	CcSEcCtD
Darunavir—Chest pain—Epirubicin—pancreatic cancer	0.000212	0.000325	CcSEcCtD
Darunavir—Agitation—Doxorubicin—pancreatic cancer	0.000212	0.000324	CcSEcCtD
Darunavir—Anxiety—Epirubicin—pancreatic cancer	0.000211	0.000323	CcSEcCtD
Darunavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.00021	0.000322	CcSEcCtD
Darunavir—Discomfort—Epirubicin—pancreatic cancer	0.000209	0.000321	CcSEcCtD
Darunavir—Malaise—Doxorubicin—pancreatic cancer	0.000208	0.000318	CcSEcCtD
Darunavir—Dry mouth—Epirubicin—pancreatic cancer	0.000207	0.000317	CcSEcCtD
Darunavir—Vertigo—Doxorubicin—pancreatic cancer	0.000207	0.000317	CcSEcCtD
Darunavir—Syncope—Doxorubicin—pancreatic cancer	0.000207	0.000316	CcSEcCtD
Darunavir—Leukopenia—Doxorubicin—pancreatic cancer	0.000206	0.000316	CcSEcCtD
Darunavir—Diarrhoea—Docetaxel—pancreatic cancer	0.000206	0.000316	CcSEcCtD
Darunavir—Confusional state—Epirubicin—pancreatic cancer	0.000205	0.000314	CcSEcCtD
Darunavir—Palpitations—Doxorubicin—pancreatic cancer	0.000203	0.000312	CcSEcCtD
Darunavir—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000202	0.00031	CcSEcCtD
Darunavir—Cough—Doxorubicin—pancreatic cancer	0.000201	0.000308	CcSEcCtD
Darunavir—Shock—Epirubicin—pancreatic cancer	0.0002	0.000306	CcSEcCtD
Darunavir—Convulsion—Doxorubicin—pancreatic cancer	0.0002	0.000306	CcSEcCtD
Darunavir—Nervous system disorder—Epirubicin—pancreatic cancer	0.000199	0.000305	CcSEcCtD
Darunavir—Dizziness—Docetaxel—pancreatic cancer	0.000199	0.000305	CcSEcCtD
Darunavir—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000199	0.000305	CcSEcCtD
Darunavir—Hypertension—Doxorubicin—pancreatic cancer	0.000199	0.000304	CcSEcCtD
Darunavir—Tachycardia—Epirubicin—pancreatic cancer	0.000198	0.000304	CcSEcCtD
Darunavir—Skin disorder—Epirubicin—pancreatic cancer	0.000197	0.000302	CcSEcCtD
Darunavir—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000196	0.000301	CcSEcCtD
Darunavir—Myalgia—Doxorubicin—pancreatic cancer	0.000196	0.0003	CcSEcCtD
Darunavir—Arthralgia—Doxorubicin—pancreatic cancer	0.000196	0.0003	CcSEcCtD
Darunavir—Chest pain—Doxorubicin—pancreatic cancer	0.000196	0.0003	CcSEcCtD
Darunavir—Anxiety—Doxorubicin—pancreatic cancer	0.000195	0.000299	CcSEcCtD
Darunavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000195	0.000298	CcSEcCtD
Darunavir—Discomfort—Doxorubicin—pancreatic cancer	0.000194	0.000297	CcSEcCtD
Darunavir—Anorexia—Epirubicin—pancreatic cancer	0.000194	0.000297	CcSEcCtD
Darunavir—Dry mouth—Doxorubicin—pancreatic cancer	0.000192	0.000294	CcSEcCtD
Darunavir—Vomiting—Docetaxel—pancreatic cancer	0.000191	0.000293	CcSEcCtD
Darunavir—Rash—Docetaxel—pancreatic cancer	0.00019	0.000291	CcSEcCtD
Darunavir—Dermatitis—Docetaxel—pancreatic cancer	0.00019	0.000291	CcSEcCtD
Darunavir—Confusional state—Doxorubicin—pancreatic cancer	0.000189	0.00029	CcSEcCtD
Darunavir—Headache—Docetaxel—pancreatic cancer	0.000189	0.000289	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000185	0.000283	CcSEcCtD
Darunavir—Shock—Doxorubicin—pancreatic cancer	0.000185	0.000283	CcSEcCtD
Darunavir—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000184	0.000282	CcSEcCtD
Darunavir—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000184	0.000282	CcSEcCtD
Darunavir—Insomnia—Epirubicin—pancreatic cancer	0.000184	0.000281	CcSEcCtD
Darunavir—Tachycardia—Doxorubicin—pancreatic cancer	0.000183	0.000281	CcSEcCtD
Darunavir—Skin disorder—Doxorubicin—pancreatic cancer	0.000183	0.00028	CcSEcCtD
Darunavir—Paraesthesia—Epirubicin—pancreatic cancer	0.000182	0.000279	CcSEcCtD
Darunavir—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000182	0.000278	CcSEcCtD
Darunavir—Dyspnoea—Epirubicin—pancreatic cancer	0.000181	0.000277	CcSEcCtD
Darunavir—Somnolence—Epirubicin—pancreatic cancer	0.000181	0.000277	CcSEcCtD
Darunavir—Anorexia—Doxorubicin—pancreatic cancer	0.000179	0.000274	CcSEcCtD
Darunavir—Nausea—Docetaxel—pancreatic cancer	0.000179	0.000274	CcSEcCtD
Darunavir—Dyspepsia—Epirubicin—pancreatic cancer	0.000179	0.000274	CcSEcCtD
Darunavir—Decreased appetite—Epirubicin—pancreatic cancer	0.000177	0.00027	CcSEcCtD
Darunavir—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000175	0.000269	CcSEcCtD
Darunavir—Fatigue—Epirubicin—pancreatic cancer	0.000175	0.000268	CcSEcCtD
Darunavir—Constipation—Epirubicin—pancreatic cancer	0.000174	0.000266	CcSEcCtD
Darunavir—Pain—Epirubicin—pancreatic cancer	0.000174	0.000266	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000171	0.000262	CcSEcCtD
Darunavir—Insomnia—Doxorubicin—pancreatic cancer	0.00017	0.00026	CcSEcCtD
Darunavir—Paraesthesia—Doxorubicin—pancreatic cancer	0.000169	0.000258	CcSEcCtD
Darunavir—Dyspnoea—Doxorubicin—pancreatic cancer	0.000168	0.000257	CcSEcCtD
Darunavir—Feeling abnormal—Epirubicin—pancreatic cancer	0.000167	0.000256	CcSEcCtD
Darunavir—Somnolence—Doxorubicin—pancreatic cancer	0.000167	0.000256	CcSEcCtD
Darunavir—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000166	0.000254	CcSEcCtD
Darunavir—Dyspepsia—Doxorubicin—pancreatic cancer	0.000165	0.000253	CcSEcCtD
Darunavir—Decreased appetite—Doxorubicin—pancreatic cancer	0.000163	0.00025	CcSEcCtD
Darunavir—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000162	0.000249	CcSEcCtD
Darunavir—Fatigue—Doxorubicin—pancreatic cancer	0.000162	0.000248	CcSEcCtD
Darunavir—Urticaria—Epirubicin—pancreatic cancer	0.000161	0.000247	CcSEcCtD
Darunavir—Pain—Doxorubicin—pancreatic cancer	0.000161	0.000246	CcSEcCtD
Darunavir—Constipation—Doxorubicin—pancreatic cancer	0.000161	0.000246	CcSEcCtD
Darunavir—Abdominal pain—Epirubicin—pancreatic cancer	0.000161	0.000246	CcSEcCtD
Darunavir—Body temperature increased—Epirubicin—pancreatic cancer	0.000161	0.000246	CcSEcCtD
Darunavir—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000155	0.000237	CcSEcCtD
Darunavir—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000154	0.000235	CcSEcCtD
Darunavir—Hypersensitivity—Epirubicin—pancreatic cancer	0.00015	0.000229	CcSEcCtD
Darunavir—Urticaria—Doxorubicin—pancreatic cancer	0.000149	0.000229	CcSEcCtD
Darunavir—Body temperature increased—Doxorubicin—pancreatic cancer	0.000149	0.000228	CcSEcCtD
Darunavir—Abdominal pain—Doxorubicin—pancreatic cancer	0.000149	0.000228	CcSEcCtD
Darunavir—Asthenia—Epirubicin—pancreatic cancer	0.000146	0.000223	CcSEcCtD
Darunavir—Pruritus—Epirubicin—pancreatic cancer	0.000144	0.00022	CcSEcCtD
Darunavir—Diarrhoea—Epirubicin—pancreatic cancer	0.000139	0.000213	CcSEcCtD
Darunavir—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000138	0.000212	CcSEcCtD
Darunavir—Asthenia—Doxorubicin—pancreatic cancer	0.000135	0.000207	CcSEcCtD
Darunavir—Dizziness—Epirubicin—pancreatic cancer	0.000134	0.000206	CcSEcCtD
Darunavir—Pruritus—Doxorubicin—pancreatic cancer	0.000133	0.000204	CcSEcCtD
Darunavir—Vomiting—Epirubicin—pancreatic cancer	0.000129	0.000198	CcSEcCtD
Darunavir—Diarrhoea—Doxorubicin—pancreatic cancer	0.000129	0.000197	CcSEcCtD
Darunavir—Rash—Epirubicin—pancreatic cancer	0.000128	0.000196	CcSEcCtD
Darunavir—Dermatitis—Epirubicin—pancreatic cancer	0.000128	0.000196	CcSEcCtD
Darunavir—Headache—Epirubicin—pancreatic cancer	0.000127	0.000195	CcSEcCtD
Darunavir—Dizziness—Doxorubicin—pancreatic cancer	0.000124	0.00019	CcSEcCtD
Darunavir—Nausea—Epirubicin—pancreatic cancer	0.000121	0.000185	CcSEcCtD
Darunavir—Vomiting—Doxorubicin—pancreatic cancer	0.000119	0.000183	CcSEcCtD
Darunavir—Rash—Doxorubicin—pancreatic cancer	0.000118	0.000181	CcSEcCtD
Darunavir—Dermatitis—Doxorubicin—pancreatic cancer	0.000118	0.000181	CcSEcCtD
Darunavir—Headache—Doxorubicin—pancreatic cancer	0.000118	0.00018	CcSEcCtD
Darunavir—Nausea—Doxorubicin—pancreatic cancer	0.000112	0.000171	CcSEcCtD
